Cayman’s Acid Phosphatase Assay provides a convenient method for detecting AP activity in plasma, serum, urine, and semen. The assay utilizes para-nitrophenyl phosphate (pNPP) as a chromogenic substrate for the enzyme. In the first step, AP dephosphory...More
Yam, L.T. Clinical significance of the human acid phosphatases. Am J Med 56 604-616 (1974).
Vaulbourdolle, M., Clavel, J., Cynober, L., et al. Acid phosphatase and zinc in semen of subjects with no clinical evidence of prostatic disease. Clin Chem 31(6) 878-880 (1985).
Gümüs, B., Lekili, M., Uyanik, B.S., et al. Serum levels of total acid phosphatase, prostatic acid phosphatase, total and free prostate-
Bull, H., Murray, P.G., Thomas, D., et al. Acid phosphatases. Mol Pathol 55 65-72 (2002).
Li, C., Chuda, R.A., Lam, W.K.W., et al. Acid phosphatases in human plasma. J Lab Clin Med 82(3) 446-460 (1973).
Hudson, P.B., Brendler, H., and Scott, W.W. A simple method for the determination of serum acid phosphatase. J Urol 58 89-92 (1947).
Cayman Chemical's mission is to help make research possible by supplying scientists worldwide with the basic research tools necessary for advancing human and animal health. Our utmost commitment to healthcare researchers is to offer the highest quality products with an affordable pricing policy.
Our scientists are experts in the synthesis, purification, and characterization of biochemicals ranging from small drug-like heterocycles to complex biolipids, fatty acids, and many others. We are also highly skilled in all aspects of assay and antibody development, protein expression, crystallization, and structure determination.
Over the past thirty years, Cayman developed a deep knowledge base in lipid biochemistry, including research involving the arachidonic acid cascade, inositol phosphates, and cannabinoids. This knowledge enabled the production of reagents of exceptional quality for cancer, oxidative injury, epigenetics, neuroscience, inflammation, metabolism, and many additional lines of research.
Our organic and analytical chemists specialize in the rapid development of manufacturing processes and analytical methods to carry out clinical and commercial GMP-API production. Pre-clinical drug discovery efforts are currently underway in the areas of bone restoration and repair, muscular dystrophy, oncology, and inflammation. A separate group of Ph.D.-level scientists are dedicated to offering Hit-to-Lead Discovery and Profiling Services for epigenetic targets. Our knowledgeable chemists can be contracted to perform complete sample analysis for analytes measured by the majority of our assays. We also offer a wide range of analytical services using LC-MS/MS, HPLC, GC, and many other techniques.
ISO Guide 34:2009
Cayman is a leader in the field of emerging drugs of abuse, providing high-purity Schedule I-V Controlled Substances to federally-licensed laboratories and qualified academic research institutions for forensic analyses. We are certified by ACLASS Accreditation Services with dual accreditation to ISO/IEC 17025:2005 and ISO Guide 34:2009.